Case report highlights accessibility issues of glucantime in Senegal, suggesting improvements in control programs.
Cutaneous leishmaniasis causes a problem of management in Senegal. Herein, we report a case illustrating this problem. A 55-year-old patient from Dahra Djoloff (260 km north of Dakar) developed diffuse cutaneous leishmaniasis due to Leishmania major. The management was hampered by the unavailability of Glucantime in the country. Despite the endemicity of leishmaniasis and the existence of NTD control programs, Glucantime remains inaccessible in Senegal. Leishmaniasis control policies should focus on the problems of the patient, particularly the accessibility of glucantime.
No takes yet. Share an insight, caveat, or question.
Diadié et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: